Alzheimer's Association
The field's rapid advances make securing reimbursement an important area of focus, researchers in a recent commentary argued.
The diagnostic firm's approach involves testing for tau that's bound to small lipid particles known as extracellular vesicles using its APEX platform.
Two blood-based biomarkers, percentage of p-tau 217 and amyloid-beta 42/40 ratio, predicted the presence of beta-amyloid plaque in patients' PET scans.
New Alzheimer's Association Guidelines Emphasize Biological Criteria for Diagnosing, Staging Disease
The authors said the updated guidelines reflect the approval of new anti-amyloid drugs and the development of blood-based biomarkers for the disease.
FDA's recommendation that Alzheimer's patients be tested for APOE status prior to starting the drug could lead to new regulatory approvals and payor coverage.